Tag: Cancer: Esophageal
One-Fourth of Esophageal Cancers Among Those With BE Missed in Year Before Diagnosis
Authors say there is need to improve effectiveness of screening and surveillance practices for early cancer detection in patients with Barrett esophagus
Overweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
Risk not reduced with aspirin use three or more times per week for colorectal and noncolorectal cancers
Survival Similar for Early, Delayed Surgery in Stage I Esophageal Cancer
For patients with stage II/III esophageal cancer, five-year survival is improved with early versus delayed esophagectomy
DDW: ‘Alarming’ Rise in Esophageal Cancer, Barrett Esophagus Seen in Middle-Age
Number of endoscopies performed not increasing, despite increased prevalence
Guidelines Updated for Barrett Esophagus Diagnosis, Management
Guideline revised to synthesize current best practices in the management of Barrett esophagus
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma
Overall survival longer in patients receiving first-line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone
Prehabilitation Exercise Intervention Studied in Esophageal Cancer
Structured prehabilitation exercise during neoadjuvant chemotherapy and surgery may enhance treatment response
More Frequent Alcohol Consumption Ups Risk for GI Cancers
Amount of alcohol consumed in each occasion seems to be a less important risk factor
Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
FDA granted Opdivo first approval of immunotherapy for first-line treatment of advanced or metastatic gastric cancer
Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
Those 70 years and older have similar postoperative complication scores and long-term survival
